Who
Jean Luc Butel
Director
Company insider
Files Form 4 as: Director, Rani Therapeutics Holdings; Director, Varian Medical Systems; Corporate Vice President, Baxter International; EVP & Group Pres MDT Intl, Medtronic.
In numbers
- Trades disclosed
- 81
- Buys
- 1
- Sells
- 2
- Bought
- $103K
- Sold
- $2.3M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 20 Dec 2004
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 28 May 2025filed 30 May 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —101,276 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,875 | filing |
| 16 Dec 2024filed 17 Dec 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,875 | filing |
| 29 May 2024filed 30 May 2024 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —101,276 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —18,875 | filing |
| 16 Dec 2023filed 19 Dec 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,875 | filing |
| 17 Nov 2023filed 21 Nov 2023 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Bought | $103K50,500 at $2.03 | filing |
| 25 May 2023filed 30 May 2023 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,276 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,416 at $0.00 | filing |
| 15 Apr 2021filed 16 Apr 2021 | Varian Medical Systemsoption or derivative | SEC FORM 4 Code D | —1,022 | filing |
| 15 Apr 2021filed 16 Apr 2021 | Varian Medical Systems | SEC FORM 4 Code D | —4,048 | filing |
| 16 Feb 2021filed 17 Feb 2021 | Varian Medical Systems | SEC FORM 4 Code M | —1,225 | filing |
| 16 Feb 2021filed 17 Feb 2021 | Varian Medical Systems | SEC FORM 4 Code F | $65K367 at $176.15 | filing |
| 16 Feb 2021filed 17 Feb 2021 | Varian Medical Systemsoption or derivative | SEC FORM 4 Code M | —1,225 | filing |
News
No headline names them, or the companies they trade most, lately.